PaxMedica
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PaxMedica and buy or sell other stocks, ETFs, and their options commission-free!About PXMD
PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis.
CEOHoward J. Weisman
CEOHoward J. Weisman
Employees5
Employees5
HeadquartersTarrytown, New York
HeadquartersTarrytown, New York
Founded2018
Founded2018
Employees5
Employees5
PXMD Key Statistics
Market cap1.72K
Market cap1.72K
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume11.11M
Average volume11.11M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.07
52 Week high$4.07
52 Week low$0.1471
52 Week low$0.1471
Stock Snapshot
The current PaxMedica(PXMD) stock price is $0.00, with a market capitalization of 1.72K. The stock trades at a price-to-earnings (P/E) ratio of -0.09.
On 2025-12-05, PaxMedica(PXMD) stock opened at —, reached a high of —, and a low of —.
The PaxMedica(PXMD)'s current trading volume is 0, compared to an average daily volume of 11.11M.
In the last year, PaxMedica(PXMD) shares hit a 52-week high of $4.07 and a 52-week low of $0.15.
In the last year, PaxMedica(PXMD) shares hit a 52-week high of $4.07 and a 52-week low of $0.15.
People also own
Based on the portfolios of people who own PXMD. This list is generated using Robinhood data, and it’s not a recommendation.